other material
confidence high
sentiment positive
materiality 0.60
Pasithea announces $4M tender offer for common stock at $0.70/share, expected Q3 2023
Pasithea Therapeutics Corp.
- Board authorized $4.0M tender offer to repurchase up to ~5.7M shares at $0.70 per share in cash.
- Tender offer expected to close in the third quarter of 2023.
- Executive officers and directors will not tender any shares in the offer.
- If oversubscribed, shares will be accepted on a pro rata basis.